Max Healthcare Institute Confirms Registration of Final Meeting Documents for Nigerian Subsidiary
Max Healthcare Institute Limited has received confirmation regarding the completion of the voluntary winding up process for its wholly-owned subsidiary, MHC Global Healthcare (Nigeria) Limited. The registration of the Account and Return of Final Meeting by the Corporate Affairs Commission marks a key step in the dissolution of the Nigerian entity.
The Company confirmed that the registration documents were accepted by the Corporate Affairs Commission. According to the notification received on July 29, 2026, MHC Nigeria will be formally deemed dissolved upon the expiration of three months from the date of the relevant letter issued by the Commissioner.
This process follows the voluntary liquidation initiated for MHC Global Healthcare (Nigeria) Limited. The subsidiary had previously been under review following an earlier intimation regarding its winding up.
The dissolution of MHC Nigeria is expected to have no material impact on the business or accounting policies of Max Healthcare Institute Limited, nor will it affect the financials of the parent company.
Details of the status update and key timelines related to the corporate dissolution are summarized below:
| Aspect | Detail |
|---|---|
| Entity | MHC Global Healthcare (Nigeria) Limited |
| Status Confirmed | Account and Return of Final Meeting registered by Corporate Affairs Commission |
| Dissolution Timeline | Three months from the date of the commission's letter (July 29, 2026) |
| Impact on Parent Company | No material impact on business or financials |
MAXHEALTH Stock Price Movement
On Wednesday, shares of Max Healthcare Institute Limited edged higher to close at ₹1111.40, gaining 0.65% as trading concluded. The stock saw robust activity during the session, with a volume totaling 1.4 million shares being exchanged.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.